secwatch / observer
8-K filed October 10, 2023, 7:59 PM ET ticker EDIT CIK 0001650664
leadership confidence high sentiment neutral materiality 0.50

Editas Medicine CTO and CBO Bruce Eaton to step down Jan 2, 2024

Editas Medicine, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Bruce E. Eaton

Chief Technology Officer and Chief Business Officer
EDIT · Editas Medicine, Inc.
Effective
2024-01-02
Filed
October 10, 2023, 7:59 PM ET
Bruce E. Eaton, Ph.D., Executive Vice President, Chief Technology Officer and Chief Business Officer of the Company, agreed that Dr. Eaton will step down as Chief Technology Officer and Chief Business Officer effective January 2, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Bruce E. Eaton departed as Chief Technology Officer and Chief Business Officer at Editas Medicine, Inc..

Action
stepped down
Role
Chief Technology Officer and Chief Business Officer
Exact text from the filing
Bruce E. Eaton, Ph.D., Executive Vice President, Chief Technology Officer and Chief Business Officer of the Company, agreed that Dr. Eaton will step down as Chief Technology Officer and Chief Business Officer effective January 2, 2024
View on SEC.gov

Editas Medicine, Inc. filing history →

Source: SEC EDGAR
accession 0001650664-23-000005
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.